Syncom Formulations (India) Ltd
NSE:SYNCOMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
IN |
|
Seatrium Limited
F:S8N0
|
SG |
|
S
|
Saf-Holland Se
XHAM:SFQ
|
DE |
|
W
|
Weyerhaeuser Co
DUS:WHC
|
US |
|
Horiba Ltd
TSE:6856
|
JP |
|
W
|
Wipro Ltd
XBER:WIOA
|
IN |
|
Northwest Pipe Co
F:NW7
|
US |
|
Groep Brussel Lambert NV
XBRU:GBLB
|
BE |
|
T
|
Tactile Systems Technology Inc
F:3L3
|
US |
|
A
|
Absolute Clean Energy PCL
SET:ACE
|
TH |
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
Canafarma Hemp Products Corp
F:4K9
|
CA |
|
S
|
Singapore Technologies Engineering Ltd
XMUN:SJX
|
SG |
|
J
|
JAFCO Group Co Ltd
F:JAF
|
JP |
|
R
|
Region Re Ltd
F:S590
|
AU |
|
Uniper SE
F:UN0
|
DE |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
Mesa Air Group Inc
NASDAQ:MESA
|
US |
|
S
|
Sharc International Systems Inc
F:IWIA
|
CA |
|
H
|
Hynion AS
OSE:HYN
|
NO |
|
M
|
Metro Inc
XBER:62M
|
CA |
|
Vital Metals Ltd
ASX:VML
|
AU |
|
Temenos AG
F:TE8N
|
CH |
|
Wal Mart de Mexico SAB de CV
F:4GNB
|
MX |
Bankruptcy Probability
Syncom Formulations (India) Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syncom Formulations (India) Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
13B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
264.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syncom Formulations (India) Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syncom Formulations (India) Ltd has total debt of 7m INR. This includes both short-term (7m INR) and long-term (0 INR) debt.
You can find a full breakdown on its Balance Sheet.
